메뉴 건너뛰기




Volumn 5, Issue 6 D, 2005, Pages

Adult cases of onychomycosis

(1)  Joseph, Warren S a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CICLOPIROX; TERBINAFINE;

EID: 23044496259     PISSN: 15303004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (1)

References (8)
  • 1
    • 33444478506 scopus 로고    scopus 로고
    • Understanding the Realities of Antifungal Therapy
    • Joseph WS, Scher RK. Understanding the Realities of Antifungal Therapy. Podiatry Today. 2004;17(11a).
    • (2004) Podiatry Today , vol.17 , Issue.11 A
    • Joseph, W.S.1    Scher, R.K.2
  • 2
    • 4143076893 scopus 로고    scopus 로고
    • Management of onychomycosis: Examining the role of monotherapy and dual, triple, or quadruple therapies
    • Gupta AK, Lynch LE. Management of onychomycosis: examining the role of monotherapy and dual, triple, or quadruple therapies. Cutis. 2004;74(suppl 1):5-9.
    • (2004) Cutis , vol.74 , Issue.SUPPL. 1 , pp. 5-9
    • Gupta, A.K.1    Lynch, L.E.2
  • 3
    • 0031595796 scopus 로고    scopus 로고
    • Relapses of onychomycosis after successful treatment with systemic antifungals: A three-year follow-up
    • Tosti A, Piraccini BM, Stinchi C, Colombo MD. Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up. Dermatology. 1998; 197:162-166.
    • (1998) Dermatology , vol.197 , pp. 162-166
    • Tosti, A.1    Piraccini, B.M.2    Stinchi, C.3    Colombo, M.D.4
  • 4
    • 0036207650 scopus 로고    scopus 로고
    • Long-term results in patients with onychomycosis treated with terbinofine or itraconazole
    • Heikkila H, Stubb S. Long-term results in patients with onychomycosis treated with terbinofine or itraconazole. Br J Dermatol. 2002;146:250-253.
    • (2002) Br J Dermatol , vol.146 , pp. 250-253
    • Heikkila, H.1    Stubb, S.2
  • 5
    • 0035051443 scopus 로고    scopus 로고
    • Cost effectiveness of continuous terbinafine compared with intermittent itraconazole in the treatment of dermatophyte toenail onychomycosis: An analysis based on results from the L.I.ON. study. Lamisil versus Itraconazole in Onychomycosis
    • Jansen R, Redekop WK, Rutten FF. Cost effectiveness of continuous terbinafine compared with intermittent itraconazole in the treatment of dermatophyte toenail onychomycosis: an analysis based on results from the L.I.ON. study. Lamisil versus Itraconazole in Onychomycosis. Pharmacoecanomics. 2001;19:401-410.
    • (2001) Pharmacoecanomics , vol.19 , pp. 401-410
    • Jansen, R.1    Redekop, W.K.2    Rutten, F.F.3
  • 6
    • 0036120887 scopus 로고    scopus 로고
    • Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: A 5-year blinded prospective follow-up study
    • Sigurgeirsson B, Olafsson JH, Steinsson JB, et al. Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study. Arch Dermatol. 2002;138:353-357.
    • (2002) Arch Dermatol , vol.138 , pp. 353-357
    • Sigurgeirsson, B.1    Olafsson, J.H.2    Steinsson, J.B.3
  • 7
    • 33444477596 scopus 로고    scopus 로고
    • Itraconazole US prescribing information. Sporanox (Itraconazole) Capsules Web site. Available at: http://www.sporanox.com/active/janus/en_US/assets/s px/sporanox.pdf. Accessed May 3, 2005.
    • Itraconazole US Prescribing Information.
  • 8
    • 33444456327 scopus 로고    scopus 로고
    • Terbinafine US prescribing information. Novartis Pharmaceutical Corporation Web site. Available at: http://www.pharma.us.novartis.com/product/ pi/pdf/Lam isil_tablets.pdf. Accessed May 3, 2005.
    • Terbinafine US Prescribing Information


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.